Swarnroop, a prominent pharmaceutical firm based in the State of Maharashtra, is significantly involved in the synthesis of crucial Active Pharmaceutical Ingredients (APIs), notably Compound 188062-50-2. This effort is importantly aligned with critical anti-AIDS studies, supporting international